BIOTRONIK - A Prospective Multicenter Single Arm Study to Assess the SaFety and Effectiveness of the Orsiro Mission 48-mm SiroLimus-Eluting Coronary Stent System for the Treatment Of Subjects With Atherosclerotic Lesion(s)
Latest Information Update: 24 Jan 2025
Price :
$35 *
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Stent thrombosis
- Focus Therapeutic Use
- Acronyms BIOFLOW-48
- Sponsors BIOTRONIK
- 24 Jan 2025 New trial record